CAV3 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • panel cardiomyopathy core targeting (46 genen) - HCM, DCM, ARVD/C, RCM ¹
  • WES heart disorders¹ (100.0% **)
  • WES Mendelian inherited disorders (100.0% **)
  • WES muscle disorders (100.0% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 601253
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 336

Panel

panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹

Turnaround time
8 weeks
Performing laboratory
Maastricht UMC+
€ 618

panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹



€ 618

panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Arrhythmogenic right ventricular cardiomyopathy (ARVD)
  • Conditions > Cardiovascular > Brugada syndrome
  • Conditions > Cardiovascular > Long QT syndrome
  • Conditions > Cardiovascular > Short QT syndrome
  • Conditions > Cardiovascular > Sick sinus syndrome

Turnaround time
8 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
Remarks
It includes sequencing of all coding regions of the following 27 genes ABCC9, AKAP9, ANK2, CACNA1C, CACNA2D1, CACNB2, CALM1, CASQ2, CAV3, DPP6, GPD1L, HCN4, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ8, KCNQ1, LMNA, RYR2, SCN1B, SCN3B, SCN5A, SNTA1, TNNT2, TRDN.

Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA




€ 618
Gene

CACNA1C (exon 8)- long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 320

CACNA1C (exon 8)- long QT syndrome ¹



€ 320

CACNA1C (exon 8)- long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 114205
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 320
Gene

CAV3 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 336

CAV3 - long QT syndrome ¹



€ 336
Gene

KCNE1 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 353

KCNE1 - long QT syndrome ¹



€ 353

KCNE1 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • panel Jervell and Lange-Nielsen syndrome (KCNQ1, KCNE1) ¹
  • WES comprehensive preconception carrier test ¹
  • WES hearing impairment (100.0% **)
  • WES heart disorders¹ (100.0% **)
  • WES Mendelian inherited disorders (100.0% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 176261
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 353
Gene

KCNE2 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 345

KCNE2 - long QT syndrome ¹



€ 345

KCNE2 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • WES heart disorders¹ (97.9% **)
  • WES Mendelian inherited disorders (97.9% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 603796
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 345
Gene

KCNH2 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 468

KCNH2 - long QT syndrome ¹



€ 468

KCNH2 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • panel short QT syndrome (CACNA1C (ex 8), KCNQ1, KCNH2, KCNJ2) ¹
  • WES heart disorders¹ (95.1% **)
  • WES Mendelian inherited disorders (95.1% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 152427
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 468
Gene

KCNJ2 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 361

KCNJ2 - long QT syndrome ¹



€ 361

KCNJ2 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • panel short QT syndrome (CACNA1C (ex 8), KCNQ1, KCNH2, KCNJ2) ¹
  • WES heart disorders¹ (100.0% **)
  • WES Mendelian inherited disorders (100.0% **)
  • WES muscle disorders (100.0% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600681
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 361
Gene

KCNJ5 - Long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 353

KCNJ5 - Long QT syndrome ¹



€ 353

KCNJ5 - Long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • WES heart disorders¹ (99.8% **)
  • WES Mendelian inherited disorders (99.8% **)
  • WES renal disorders (99.8% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600734
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 353
Gene

KCNJ8 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 336

KCNJ8 - long QT syndrome ¹



€ 336

KCNJ8 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • WES heart disorders¹ (100.0% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600935
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 336
Gene

KCNQ1 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 476

KCNQ1 - long QT syndrome ¹



€ 476

KCNQ1 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • panel Jervell and Lange-Nielsen syndrome (KCNQ1, KCNE1) ¹
  • panel short QT syndrome (CACNA1C (ex 8), KCNQ1, KCNH2, KCNJ2) ¹
  • WES comprehensive preconception carrier test ¹
  • WES hearing impairment (95.3% **)
  • WES heart disorders¹ (95.3% **)
  • WES Mendelian inherited disorders (95.3% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 607542
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 476
Gene

SCN5A - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 583

SCN5A - long QT syndrome ¹



€ 583

SCN5A - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • panel Arrhythmia targeting (27 genes) - LQT, SQT, BrS, CPVT, SSS ¹
  • panel cardiomyopathy (27 genes) - HCM, DCM, ARVD/C, RCM ¹
  • panel cardiomyopathy core targeting (46 genen) - HCM, DCM, ARVD/C, RCM ¹
  • panel sick sinus syndrome (SCN5A, HCN4) ¹
  • WES heart disorders¹ (99.0% **)
  • WES Mendelian inherited disorders (99.0% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 600163
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 583
Gene

TRPM4 - long QT syndrome ¹

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Maastricht UMC+
€ 476

TRPM4 - long QT syndrome ¹



€ 476

TRPM4 - long QT syndrome ¹

This test is available for the following conditions:

  • Conditions > Cardiovascular > Long QT syndrome

This product is also part of the following panels:

  • WES heart disorders¹ (99.9% **)
  • WES Mendelian inherited disorders (99.9% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 606936
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 476